tirzepatide obesity trial non-diabetic surmount-1 weight loss For the first time, and semaglutide were put in the same trial. SURMOUNT-5. Phase 3b RCT. 751 adults Tirzepatide outperforms semaglutide in NEJM
Pay in 4 interest-free payments of $7.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15


























